You are here:-David Zhang

About David Zhang

This author has not yet filled in any details.
So far David Zhang has created 46 blog entries.

7th SABPA/ACS Chemistry Symposium

DATE: Thursday, September 6, 2018 TIME: 6:00 – 6:30 PM   Registration, Networking and Light dinner 6:30 – 7:15 PM   Dr. Jinglan Zhou, “Discovery of Ivacaftor, a CFTR  for the Treatment of Cystic Fibrosis” 7:15 – 8:00 PM   Professor John L. Wood, “Recent Efforts in the Synthesis of Complex Natural Products” PLACE:  Lilly Biotechnology Center 10290 Campus

SABPA 2018 Board Election

Background: The SABPA Board of Directors (BOD) is the governing body that oversees all activities of the SABPA organization. There are twenty-one (21) board directors serving a three-year term. In 2018, there are five (5) open seats on the BOD for candidates seeking election. Eligibility: An active SABPA member who possesses a high standard of

Multiple job openings at HD Biosciences

We are hiring…… Please send your application (or question) to Scientist, in vitro pharmacology Ph.D. in Molecular Biology, Microbiology, Biochemistry or a related field Biological assay development, validation, quality control, and application in discovery research. Experience in development of SOPs, writing of research proposals and study reports. Scientist I/II, HTS and compound management Ph.D.

Biocom Educational Session: Transformative Screening Platforms for Today’s Drug Discovery

Biocom Educational Session Transformative Screening Platforms for Today’s Drug Discovery June 20th, 8-10 AM, 2018 Venue: Biocom McGraw Boardroom- 10996 Torreyana Rd. Suite 200, San Diego, CA Registration:   Do you wish to keep abreast of the new developments in cutting-edge screening technologies? Are you trying to rise to the challenge of working with

Symposium: Innovative Approaches to Drug Discovery and Development

How can we accelerate successful drug discovery and development? The success of clinical candidate development depends on several factors, important among them are generation of novel, therapeutically-relevant chemical structures, early and rapid assessment of possible efficacy of candidate structures in pre-clinical therapeutic models and rapid elimination of candidates that will ultimately prove unsuccessful. Innovative processes


正大天晴药业集团研究院国际人才招聘 公司简介 正大天晴药业集团股份有限公司是中国集科研,生产和销售为一体的大型综合型医药企业,2017年营业额人民币167亿元,在2016年度“中国医药工业百强榜”上列第16位,在2017年“中国医药研发产品线最佳工业企业”排名第1位。 招聘职位 Director, Immunotherapy (Immuno-Oncology focus) (技术总监:免疫治疗) Location Nanjing, China (中国南京) Description The successful candidate will participate in the design and validation of the next generation of immunotherapeutics. He/she will provide strategic and technical leadership across immuno-oncology projects and initiatives. In addition to supporting the expansion of our antibody portfolio, the candidate

2nd Antibody-based Therapeutics and BioProduction Forum

Event Name: Antibody-based Therapeutics and BioProduction Forum Event Date: Aug.29-31.2018 Event Venue: Shanghai, PR. China   The Antibody and Antibody-based Therapeutics have entered the center stage of drug discovery and been reflected through the major shift of focus in pipeline by pharmaceutical companies from small molecules to a broader portfolio with biologics and chemical agents.

SDEE: Get To Know Your Neighbors

Get To Know Your Neighbors Thursday, May 3rd 5:00pm - 8:00pm Location: Green Acre Campus Point Event Sponsors: Join us for our annual networking event to help find collaborators, vendors, customers, advisers and investors, jobs, employees and meet your fellow entrepreneurs in your own neighborhood.  Members can apply to give a 30 second pitch Exhibit tables

SABPA 13th Annual Biomedical Forum

The 21st SABPA Entrepreneur Symposium — Licensing of IP & Tech Transfer in Biotech Arena

Topics include: • Best Practices for Startups & Cleaning up Up Your Existing IP Rights • Introduction to Licensing • Developing a Successful Licensing Strategy • Top 10 mistakes to Avoid • Negotiating a Successful License • Bio-Pharma Example(s) The presentation and discussion will be presented by Partners at the Procopio who have years of